BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 26920143)

  • 21. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.
    Varadi V; Brendle A; Brandt A; Johansson R; Enquist K; Henriksson R; Svenson U; Tavelin B; Roos G; Hemminki K; Lenner P; Försti A
    Eur J Cancer; 2009 Nov; 45(17):3008-16. PubMed ID: 19766477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
    Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
    J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.
    Lesicka M; Jabłońska E; Wieczorek E; Pepłońska B; Gromadzińska J; Seroczyńska B; Kalinowski L; Skokowski J; Reszka E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 72Pro Variant of the Tumor Protein 53 Is Associated with an Increased Breast Cancer Risk in the Moroccan Population.
    Ayoubi SE; Elkarroumi M; El Khachibi M; Hassani Idrissi H; Ayoubi H; Ennachit S; Arazzakou M; Nadifi S
    Pathobiology; 2018; 85(4):247-253. PubMed ID: 29949804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.
    Vitiello GAF; de Sousa Pereira N; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1523-1532. PubMed ID: 32285256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
    Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
    Bayram S; Sümbül AT; Dadaş E
    Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population.
    Hashemi M; Sanaei S; Mashhadi MA; Hashemi SM; Taheri M; Ghavami S
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):69-73. PubMed ID: 26718432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer.
    Radmanesh H; Spethmann T; Enßen J; Schürmann P; Bhuju S; Geffers R; Antonenkova N; Khusnutdinova E; Sadr-Nabavi A; Shandiz FH; Park-Simon TW; Hillemanns P; Christiansen H; Bogdanova N; Dörk T
    Breast Cancer Res Treat; 2017 Feb; 162(1):31-37. PubMed ID: 28062980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population.
    Leyton Y; Gonzalez-Hormazabal P; Blanco R; Bravo T; Fernandez-Ramires R; Morales S; Landeros N; Reyes JM; Peralta O; Tapia JC; Gomez F; Waugh E; Ibañez G; Pakomio J; Grau G; Jara L
    BMC Cancer; 2015 Jan; 15():30. PubMed ID: 25636233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population.
    Deng Z; Yang H; Liu Q; Wang Z; Feng T; Ouyang Y; Jin T; Ren H
    J Hum Genet; 2016 Dec; 61(12):1027-1034. PubMed ID: 27604554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.
    Popanda O; Seibold P; Nikolov I; Oakes CC; Burwinkel B; Hausmann S; Flesch-Janys D; Plass C; Chang-Claude J; Schmezer P
    Int J Cancer; 2013 Jan; 132(1):55-62. PubMed ID: 22684821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the Tumor Necrosis Factor Genes Are Associated with Breast Cancer in the Moroccan Population.
    Aznag FZ; Elouilamine E; Korrida A; Izaabel EH
    Genet Test Mol Biomarkers; 2020 Sep; 24(9):592-599. PubMed ID: 32735459
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
    Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
    Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.
    Marouf C; Tazzite A; Diakité B; Jouhadi H; Benider A; Nadifi S
    Tumour Biol; 2014 Dec; 35(12):12403-8. PubMed ID: 25201062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
    Jiang Y; Han J; Liu J; Zhang G; Wang L; Liu F; Zhang X; Zhao Y; Pang D
    Breast Cancer Res Treat; 2011 Jul; 128(1):251-7. PubMed ID: 21197568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.